"Piroxicam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
Descriptor ID |
D010894
|
MeSH Number(s) |
D02.886.665.500 D03.383.855.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Piroxicam".
Below are MeSH descriptors whose meaning is more specific than "Piroxicam".
This graph shows the total number of publications written about "Piroxicam" by people in this website by year, and whether "Piroxicam" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 0 | 1 | 1 |
2017 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2019 | 3 | 0 | 3 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Piroxicam" by people in Profiles.
-
Coenzyme Q10 supplementation mitigates piroxicam-induced oxidative injury and apoptotic pathways in the stomach, liver, and kidney. Biomed Pharmacother. 2020 Oct; 130:110627.
-
Cadmium overload modulates piroxicam-regulated oxidative damage and apoptotic pathways. Environ Sci Pollut Res Int. 2019 Aug; 26(24):25167-25177.
-
Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial. Curr Med Res Opin. 2019 10; 35(10):1785-1792.
-
New local treatment for photoaging using a formulation containing piroxicam 0.8% and sunscreen. J Int Med Res. 2019 Jul; 47(7):3127-3132.
-
Monitoring treatment response in patients affected by actinic keratosis: Dermoscopic assessment and metalloproteinases evaluation after piroxicam 0.8% and sunfilter cream. Dermatol Ther. 2019 01; 32(1):e12772.
-
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial. Curr Med Res Opin. 2017 07; 33(7):1255-1259.
-
Lidocaine and tenoxicam effectiveness for pain relief during Pipelle: Non-randomised double-blind placebo-controlled trial. J Pak Med Assoc. 2017 Apr; 67(4):527-533.
-
IBD: of mice and men-shedding new light on IL-13 activity in IBD. Nat Rev Gastroenterol Hepatol. 2011 Mar; 8(3):128-9.